LEXX · Lexaria Bioscience Corp.
$5.34
-0.33 (-5.82%)
At close · Aug 6
View the 10-Q filed Jul 13, 2026
Going-concern doubt
— flagged Jul 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The recurring losses and negative net cash flows raise substantial doubt as to the Company's ability to continue as a going concern.”View the 10-Q filed Jul 13, 2026
Customer concentration
— top customer 100% of revenue
One customer — 100% of revenue (nine months ended May 31, 2026)
“In the nine months ended May 31, 2026, the Company recognized revenue of $20,000 on a consolidated basis. One customer accounted for 100% of that total.”
2 customers — 100% of revenue (nine months ended May 31, 2025)
“In the nine months ended May 31, 2025, the Company recognized revenue of $531,923 on a consolidated basis. Two customers accounted for 100% of that total.”
Market Cap
$132.36M
Shares
24.79M
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
The Jun 30, 2026 filing window is
still open — showing the latest known positions. Funds that have not filed yet
carry their prior-quarter positions; a fund that filed without this stock counts
as sold out. Pick a completed quarter in the Quarter selector
below to see a single quarter with position changes.
Holders: 27
Total Value: $279,085
Total Shares: 1,489,879
Institutional Ownership Trend
22 quarters
Holder Concentration
Across 28 13F filersTop Holder
68.0%
of institutional value
Top 5
100.0%
of institutional value
Top 10
100.0%
of institutional value
HHI
5,471
Highly concentrated